| Primary |
| Hormone Replacement Therapy |
41.5% |
| Hormone Therapy |
7.3% |
| Hypertension |
6.5% |
| Arthritis |
5.7% |
| Oestrogen Replacement Therapy |
4.9% |
| Off Label Use |
4.9% |
| Migraine |
3.3% |
| Anxiety |
2.4% |
| Back Pain |
2.4% |
| Depression |
2.4% |
| Dyspepsia |
2.4% |
| Hot Flush |
2.4% |
| Pain |
2.4% |
| Sleep Disorder |
2.4% |
| Thyroidectomy |
2.4% |
| Ill-defined Disorder |
1.6% |
| Menopause |
1.6% |
| Postmenopause |
1.6% |
| Diuretic Therapy |
0.8% |
| Dysthymic Disorder |
0.8% |
|
| Drug Ineffective |
22.7% |
| Breast Cancer Female |
11.4% |
| Injection Site Abscess |
9.1% |
| Poor Quality Drug Administered |
6.8% |
| Hot Flush |
4.5% |
| Injection Site Nodule |
4.5% |
| Pneumonectomy |
4.5% |
| Product Quality Issue |
4.5% |
| Skin Burning Sensation |
4.5% |
| Subcutaneous Abscess |
4.5% |
| Abdominal Discomfort |
2.3% |
| Bone Pain |
2.3% |
| Breast Mass |
2.3% |
| Breast Pain |
2.3% |
| Cardiac Valve Disease |
2.3% |
| Coeliac Disease |
2.3% |
| Condition Aggravated |
2.3% |
| Dizziness |
2.3% |
| Gallbladder Operation |
2.3% |
| Hyperhidrosis |
2.3% |
|
| Secondary |
| Hormone Replacement Therapy |
34.6% |
| Menopause |
21.9% |
| Pain |
6.5% |
| Depression |
3.7% |
| Anxiety |
3.2% |
| Nausea |
3.2% |
| Oestrogen Replacement Therapy |
3.0% |
| Cardiac Disorder |
2.6% |
| Herpes Virus Infection |
2.6% |
| Meniere's Disease |
2.6% |
| Blood Pressure Management |
2.2% |
| Cerebrovascular Accident Prophylaxis |
2.2% |
| Hypercholesterolaemia |
2.2% |
| Menopausal Symptoms |
1.7% |
| Hormone Therapy |
1.5% |
| Hypertension |
1.5% |
| Migraine |
1.3% |
| Off Label Use |
1.3% |
| Post Laminectomy Syndrome |
1.3% |
| Blood Cholesterol |
0.9% |
|
| Breast Cancer |
27.6% |
| Breast Cancer Female |
14.9% |
| Pain |
13.8% |
| Breast Cancer Metastatic |
11.5% |
| Upper Limb Fracture |
4.6% |
| Gallbladder Disorder |
3.4% |
| Myocardial Infarction |
3.4% |
| Ovarian Cancer |
3.4% |
| Skin Burning Sensation |
2.3% |
| Skin Induration |
2.3% |
| Thrombosis |
2.3% |
| Drug Ineffective |
1.1% |
| Endometriosis |
1.1% |
| Hair Growth Abnormal |
1.1% |
| Hyperhidrosis |
1.1% |
| Injection Site Nodule |
1.1% |
| Malaise |
1.1% |
| Metastases To Lung |
1.1% |
| Nasopharyngitis |
1.1% |
| Nervousness |
1.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
14.8% |
| Drug Use For Unknown Indication |
13.5% |
| Restless Legs Syndrome |
13.5% |
| Back Pain |
7.4% |
| Pain |
5.1% |
| Asthma |
4.7% |
| Depression |
4.7% |
| Anxiety |
4.4% |
| Hormone Replacement Therapy |
4.4% |
| Hypertension |
4.0% |
| Epicondylitis |
3.4% |
| Insomnia |
3.4% |
| Rheumatoid Arthritis |
2.4% |
| Sleep Disorder |
2.4% |
| Chronic Obstructive Pulmonary Disease |
2.0% |
| Dysaesthesia |
2.0% |
| Epilepsy |
2.0% |
| Hot Flush |
2.0% |
| Nutritional Support |
2.0% |
| Pain In Extremity |
2.0% |
|
| Migraine |
21.4% |
| Road Traffic Accident |
10.7% |
| Weight Decreased |
10.7% |
| Convulsion |
7.1% |
| Type 2 Diabetes Mellitus |
7.1% |
| Anaphylactic Reaction |
5.4% |
| Vomiting |
5.4% |
| Death |
3.6% |
| Suicide Attempt |
3.6% |
| Surgical Failure |
3.6% |
| Tooth Abscess |
3.6% |
| Urticaria |
3.6% |
| Adverse Event |
1.8% |
| Asthenia |
1.8% |
| Bone Disorder |
1.8% |
| Bronchitis |
1.8% |
| Chest Discomfort |
1.8% |
| Coronary Artery Occlusion |
1.8% |
| Dehydration |
1.8% |
| Depression |
1.8% |
|
